Cost-effectiveness of a police education program on HIV and overdose among people who inject drugs in Tijuana, Mexico.

Cost-effectiveness HIV Law enforcement Modelling Overdose Structural intervention

Journal

Lancet regional health. Americas
ISSN: 2667-193X
Titre abrégé: Lancet Reg Health Am
Pays: England
ID NLM: 9918232503006676

Informations de publication

Date de publication:
Feb 2024
Historique:
received: 21 06 2023
revised: 05 01 2024
accepted: 12 01 2024
medline: 8 2 2024
pubmed: 8 2 2024
entrez: 8 2 2024
Statut: epublish

Résumé

Incarceration is associated with drug-related harms among people who inject drugs (PWID). We trained >1800 police officers in Tijuana, Mexico on occupational safety and HIV/HCV, harm reduction, and decriminalization reforms (Proyecto Escudo). We evaluated its effect on incarceration, population impact and cost-effectiveness on HIV and fatal overdose among PWID. We assessed self-reported recent incarceration in a longitudinal cohort of PWID before and after Escudo. Segmented regression was used to compare linear trends in log risk of incarceration among PWID pre-Escudo (2012-2015) and post-Escudo (2016-2018). We estimated population impact using a dynamic model of HIV transmission and fatal overdose among PWID, with incarceration associated with syringe sharing and fatal overdose. The model was calibrated to HIV and incarceration patterns in Tijuana. We compared a scenario with Escudo (observed incarceration declines for 2 years post-Escudo among PWID from the segmented regression) compared to a counterfactual of no Escudo (continuation of stable pre-Escudo trends), assessing cost-effectiveness from a societal perspective. Using a 2-year intervention effect and 50-year time horizon, we determined the incremental cost-effectiveness ratio (ICER, in 2022 USD per disability-adjusted life years [DALYs] averted). Compared to stable incarceration pre-Escudo, for every three-month interval in the post-Escudo period, recent incarceration among PWID declined by 21% (adjusted relative risk = 0.79, 95% CI: 0.68-0.91). Based on these declines, we estimated 1.7% [95% interval: 0.7%-3.5%] of new HIV cases and 12.2% [4.5%-26.6%] of fatal overdoses among PWID were averted in the 2 years post-Escudo, compared to a counterfactual without Escudo. Escudo was cost-effective (ICER USD 3746/DALY averted compared to a willingness-to-pay threshold of $4842-$13,557). Escudo is a cost-effective structural intervention that aligned policing practices and human-rights-based public health practices, which could serve as a model for other settings where policing constitutes structural HIV and overdose risk among PWID. National Institute on Drug Abuse, UC MEXUS CONACyT, and the San Diego Center for AIDS Research (SD CFAR).

Sections du résumé

Background UNASSIGNED
Incarceration is associated with drug-related harms among people who inject drugs (PWID). We trained >1800 police officers in Tijuana, Mexico on occupational safety and HIV/HCV, harm reduction, and decriminalization reforms (Proyecto Escudo). We evaluated its effect on incarceration, population impact and cost-effectiveness on HIV and fatal overdose among PWID.
Methods UNASSIGNED
We assessed self-reported recent incarceration in a longitudinal cohort of PWID before and after Escudo. Segmented regression was used to compare linear trends in log risk of incarceration among PWID pre-Escudo (2012-2015) and post-Escudo (2016-2018). We estimated population impact using a dynamic model of HIV transmission and fatal overdose among PWID, with incarceration associated with syringe sharing and fatal overdose. The model was calibrated to HIV and incarceration patterns in Tijuana. We compared a scenario with Escudo (observed incarceration declines for 2 years post-Escudo among PWID from the segmented regression) compared to a counterfactual of no Escudo (continuation of stable pre-Escudo trends), assessing cost-effectiveness from a societal perspective. Using a 2-year intervention effect and 50-year time horizon, we determined the incremental cost-effectiveness ratio (ICER, in 2022 USD per disability-adjusted life years [DALYs] averted).
Findings UNASSIGNED
Compared to stable incarceration pre-Escudo, for every three-month interval in the post-Escudo period, recent incarceration among PWID declined by 21% (adjusted relative risk = 0.79, 95% CI: 0.68-0.91). Based on these declines, we estimated 1.7% [95% interval: 0.7%-3.5%] of new HIV cases and 12.2% [4.5%-26.6%] of fatal overdoses among PWID were averted in the 2 years post-Escudo, compared to a counterfactual without Escudo. Escudo was cost-effective (ICER USD 3746/DALY averted compared to a willingness-to-pay threshold of $4842-$13,557).
Interpretation UNASSIGNED
Escudo is a cost-effective structural intervention that aligned policing practices and human-rights-based public health practices, which could serve as a model for other settings where policing constitutes structural HIV and overdose risk among PWID.
Funding UNASSIGNED
National Institute on Drug Abuse, UC MEXUS CONACyT, and the San Diego Center for AIDS Research (SD CFAR).

Identifiants

pubmed: 38327278
doi: 10.1016/j.lana.2024.100679
pii: S2667-193X(24)00006-1
pmc: PMC10847144
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100679

Informations de copyright

© 2024 The Author(s).

Déclaration de conflit d'intérêts

JAC and SS report research grants from NIH. NM reports research grants from NIH and unrestricted research grants from Gilead and Abbvie unrelated to this work; and Leadership or fiduciary role for the International Network on Health and Hepatitis in Substance Users. All other authors declare no interests.

Auteurs

Javier A Cepeda (JA)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Leo Beletsky (L)

School of Law, Bouvé College of Health Sciences, Northeastern University, Boston, MA, USA.
Division of Infectious Diseases and Global Public Health, University of California, San Diego, CA, USA.

Daniela Abramovitz (D)

Division of Infectious Diseases and Global Public Health, University of California, San Diego, CA, USA.

Carlos Rivera Saldana (CR)

Division of Infectious Diseases and Global Public Health, University of California, San Diego, CA, USA.

James G Kahn (JG)

Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco, CA, USA.

Arnulfo Bañuelos (A)

Independent Policing Consultant, Tijuana, Mexico.

Gudelia Rangel (G)

Mexico Section, U.S.-Mexico Border Health Commission, Tijuana, Mexico.

Jaime Arredondo (J)

Canadian Institute for Substance Use Research, University of Victoria, BC, Canada.

Peter Vickerman (P)

Population Health Science Institute, University of Bristol, UK.

Annick Bórquez (A)

Division of Infectious Diseases and Global Public Health, University of California, San Diego, CA, USA.

Steffanie A Strathdee (SA)

Division of Infectious Diseases and Global Public Health, University of California, San Diego, CA, USA.

Natasha K Martin (NK)

Division of Infectious Diseases and Global Public Health, University of California, San Diego, CA, USA.
Population Health Science Institute, University of Bristol, UK.

Classifications MeSH